Climb Bio, Inc. (CLYM) Tops Q2 EPS by 5c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q2 EPS of ($0.13), $0.05 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Hertz cuts guidance, announces notes and stock offerings, shares sink
• Crown Crafts (CRWS) Reports Q4 EPS of $0.03
• Quantum Cyber says its platform aligns with Trump quantum executive order